Infectious Diseases

Top Story

Study: Fidaxomicin ‘better’ option than vancomycin in many C. difficile cases

Study: Fidaxomicin ‘better’ option than vancomycin in many <i>C. dif</i><i>f</i><i>icile</i> cases
July 19, 2018
In the Journals

Medical male circumcision averts new HIV infections, saves costs in Zimbabwe

July 19, 2018
Voluntary medical male circumcision may save costs in the long term and has already impacted the future of Zimbabwe’s HIV epidemic by averting new infections…
FDA NewsPerspective

Janssen receives FDA approval for Symtuza

July 18, 2018
Janssen announced that it has received FDA approval for Symtuza, a once-daily, single-tablet, darunavir-based HIV-1 regimen for treatment-naive and certain virologically…
FDA News

FDA expands Intelence label to include young children with HIV

July 18, 2018
The FDA has approved labeling changes for Intelence to expand treatment for HIV-infected patents aged 2 to 6 years and weighing at least 10 kg. The dose for Intelence…
More Headlines »
CME CNE CPE CE

Problem Based Learning in HBV: A Patient Simulation for Improving Treatment Decisions and Long-Term Care

Hepatitis B virus (HBV) infection is a largely undetected and untreated disease in the United States despite the…
More »
GI Bookshelf

Chapter 6: Infections In IBD - Clostridium difficile and Cytomegalovirus

From Clinical Challenges and Complications of IBD
More »
Resource Centers
Zika Resource Center

Zika Resource Center

Video
Meeting News

Women on HRT, birth control safely, effectively treated HCV with Zepatier

April 14, 2018
More »